Mass spectrometry analysis of human ALS or FTD tissue has been limited to unfractionated brain homogenates rather than TDP-43 inclusion-specific fractions and has therefore predominantly revealed alterations linked to pathways reflecting neurodegeneration and inflammation more broadly [29, 38, 40]. Here, TARDBP is linked to frontotemporal dementia.